CC-5013: 38 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
38
Total FAERS Reports
13 (34.2%)
Deaths Reported
17
Hospitalizations
38
As Primary/Secondary Suspect
5
Life-Threatening
4
Disabilities
First Report: 20101117 · Latest Report: 20140422
What Are the Most Common CC-5013 Side Effects?
#1 Most Reported
Squamous cell carcinoma of skin
3 reports (7.9%)
#2 Most Reported
Invasive ductal breast carcinoma
3 reports (7.9%)
#3 Most Reported
Thrombocytopenia
2 reports (5.3%)
All CC-5013 Side Effects by Frequency
No side effect data available.
Who Reports CC-5013 Side Effects? Age & Gender Data
Average age: 71.7 years. Most reports from: US. View detailed demographics →
Is CC-5013 Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 1 | 1 |
| 2011 | 3 | 1 | 0 |
| 2012 | 6 | 3 | 2 |
| 2013 | 20 | 5 | 11 |
| 2014 | 7 | 2 | 3 |
What Is CC-5013 Used For?
| Indication | Reports |
|---|---|
| Chronic lymphocytic leukaemia | 15 |
| Plasma cell myeloma | 9 |
| Mantle cell lymphoma | 5 |
Official FDA Label for CC-5013
Official prescribing information from the FDA-approved drug label.